1. Home
  2. BLFS vs ABCL Comparison

BLFS vs ABCL Comparison

Compare BLFS & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BioLife Solutions Inc.

BLFS

BioLife Solutions Inc.

HOLD

Current Price

$24.61

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$3.73

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLFS
ABCL
Founded
1987
2012
Country
United States
Canada
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.1B
IPO Year
1989
2020

Fundamental Metrics

Financial Performance
Metric
BLFS
ABCL
Price
$24.61
$3.73
Analyst Decision
Strong Buy
Buy
Analyst Count
4
5
Target Price
$31.50
$7.75
AVG Volume (30 Days)
352.6K
4.0M
Earning Date
11-06-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$100,144,000.00
$35,325,000.00
Revenue This Year
$20.67
$25.45
Revenue Next Year
$14.13
$10.07
P/E Ratio
N/A
N/A
Revenue Growth
87.53
7.17
52 Week Low
$19.10
$1.89
52 Week High
$29.62
$6.52

Technical Indicators

Market Signals
Indicator
BLFS
ABCL
Relative Strength Index (RSI) 40.40 42.31
Support Level $24.68 $3.51
Resistance Level $25.96 $3.73
Average True Range (ATR) 1.05 0.19
MACD -0.08 0.08
Stochastic Oscillator 20.73 76.00

Price Performance

Historical Comparison
BLFS
ABCL

About BLFS BioLife Solutions Inc.

BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

Share on Social Networks: